Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0457 USD | +3.39% | -8.60% | -25.69% |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Apr. 11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 176M |
---|---|---|---|---|---|
Net income 2021 | -122M | Net income 2022 | -115M | EV / Sales 2021 | - |
Net cash position 2021 | 12.15M | Net Debt 2022 | 3.2M | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.63
x | P/E ratio 2022 |
-1.23
x | Employees | 66 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.86% |
Latest transcript on Evelo Biosciences, Inc.
1 day | +3.39% | ||
1 week | -8.60% | ||
Current month | +1.56% | ||
1 month | -8.60% | ||
3 months | -32.70% | ||
6 months | -93.28% | ||
Current year | -25.69% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | Nov. 20 |
Andrea Itano
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Duncan McHale
CTO | Chief Tech/Sci/R&D Officer | 57 | 18-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | Nov. 20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.0457 | +3.39% | 488 |
24-04-24 | 0.0442 | +4.00% | 1,279 |
24-04-23 | 0.0425 | -2.41% | 1,465 |
24-04-22 | 0.0436 | -12.02% | 17,565 |
24-04-19 | 0.0495 | -1.00% | 3,995 |
Delayed Quote OTC Markets, April 25, 2024 at 11:33 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-25.69% | 868K | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- EVLO Stock